Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions
This article discusses dried blood spot (DBS) sampling in therapeutic drug monitoring (TDM). The most important advantages of DBS sampling in TDM are the minimally invasive procedure of a finger prick (home sampling), the small volume (children), and the stability of the analyte. Many assays in DBS...
Gespeichert in:
| Veröffentlicht in: | Clinical pharmacokinetics 2014-11, Vol.53 (11), p.961-973 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 973 |
|---|---|
| container_issue | 11 |
| container_start_page | 961 |
| container_title | Clinical pharmacokinetics |
| container_volume | 53 |
| creator | Wilhelm, Abraham J. den Burger, Jeroen C. G. Swart, Eleonora L. |
| description | This article discusses dried blood spot (DBS) sampling in therapeutic drug monitoring (TDM). The most important advantages of DBS sampling in TDM are the minimally invasive procedure of a finger prick (home sampling), the small volume (children), and the stability of the analyte. Many assays in DBS have been reported in the literature over the previous 5 years. These assays and their analytical techniques are reviewed here. Factors that may influence the accuracy and reproducibility of DBS methods are also discussed. Important issues are the correlation with plasma/serum concentrations and the influence of hematocrit on spot size and recovery. The different substrate materials are considered. DBS sampling can be a valid alternative to conventional venous sampling. However, patient correlation studies are indispensable to prove this. Promising developments are dried plasma spots using membrane and hematocrit correction using the potassium concentration. |
| doi_str_mv | 10.1007/s40262-014-0177-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4213377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1619313640</sourcerecordid><originalsourceid>FETCH-LOGICAL-c566t-57591d26ea4c175998384bee1d96ddf803b69b6e82999e2d8a388f6e265e635d3</originalsourceid><addsrcrecordid>eNp1kV-LFSEYhyWK9nTqA3QTQgTdTPlvdOwiqD1tBRsFbXQpzvjOWZc5OqkT7LfPwzltW9CFKPr48319EHpMyQtKiHqZBWGSNYSKOpRq1B20olTphmom76IV4ZQ1rZb8BD3I-YoQ0jFC7qMT1jIiBOEr9P3iEpKdYSl-wJu0bPGnGHyJyYct7q_rlgeH304xOvx1juUV_pLiNkHOuES8sQWwDQ6fLWVJgDc-wVB8DPkhujfaKcOj47xG387eXZx-aM4_v_94-ua8GVopS9OqVlPHJFgx0LrWHe9ED0Cdls6NHeG91L2EjmmtgbnO8q4bJTDZguSt42v0-pA7L_0O3AChJDuZOfmdTdcmWm_-Pgn-0mzjTyMY5VypGvD8GJDijwVyMTufB5gmGyAu2VBJNadc1t9ao6f_oFdxSaG2VylBFNdE80rRAzWkmHOC8aYYSsxemzloM1Wb2Wsz-yKe3O7i5sZvTxV4dgRsHuw0JhsGn_9wneZCCVY5duDyvDcI6VaJ_339F2iErug</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1640739093</pqid></control><display><type>article</type><title>Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Wilhelm, Abraham J. ; den Burger, Jeroen C. G. ; Swart, Eleonora L.</creator><creatorcontrib>Wilhelm, Abraham J. ; den Burger, Jeroen C. G. ; Swart, Eleonora L.</creatorcontrib><description>This article discusses dried blood spot (DBS) sampling in therapeutic drug monitoring (TDM). The most important advantages of DBS sampling in TDM are the minimally invasive procedure of a finger prick (home sampling), the small volume (children), and the stability of the analyte. Many assays in DBS have been reported in the literature over the previous 5 years. These assays and their analytical techniques are reviewed here. Factors that may influence the accuracy and reproducibility of DBS methods are also discussed. Important issues are the correlation with plasma/serum concentrations and the influence of hematocrit on spot size and recovery. The different substrate materials are considered. DBS sampling can be a valid alternative to conventional venous sampling. However, patient correlation studies are indispensable to prove this. Promising developments are dried plasma spots using membrane and hematocrit correction using the potassium concentration.</description><identifier>ISSN: 0312-5963</identifier><identifier>EISSN: 1179-1926</identifier><identifier>DOI: 10.1007/s40262-014-0177-7</identifier><identifier>PMID: 25204403</identifier><identifier>CODEN: CPKNDH</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Biological and medical sciences ; Blood Specimen Collection ; Dried Blood Spot Testing - methods ; Dried Blood Spot Testing - trends ; Drug Monitoring - methods ; Drug Monitoring - trends ; General pharmacology ; Hematocrit ; Humans ; Immunosuppressive Agents - blood ; Internal Medicine ; Medical sciences ; Medicine ; Medicine & Public Health ; Netherlands ; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Pharmacotherapy ; Plasma - chemistry ; Reproducibility of Results ; Review ; Review Article ; Tandem Mass Spectrometry</subject><ispartof>Clinical pharmacokinetics, 2014-11, Vol.53 (11), p.961-973</ispartof><rights>The Author(s) 2014</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Springer Science & Business Media Nov 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c566t-57591d26ea4c175998384bee1d96ddf803b69b6e82999e2d8a388f6e265e635d3</citedby><cites>FETCH-LOGICAL-c566t-57591d26ea4c175998384bee1d96ddf803b69b6e82999e2d8a388f6e265e635d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40262-014-0177-7$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40262-014-0177-7$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28934742$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25204403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilhelm, Abraham J.</creatorcontrib><creatorcontrib>den Burger, Jeroen C. G.</creatorcontrib><creatorcontrib>Swart, Eleonora L.</creatorcontrib><title>Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions</title><title>Clinical pharmacokinetics</title><addtitle>Clin Pharmacokinet</addtitle><addtitle>Clin Pharmacokinet</addtitle><description>This article discusses dried blood spot (DBS) sampling in therapeutic drug monitoring (TDM). The most important advantages of DBS sampling in TDM are the minimally invasive procedure of a finger prick (home sampling), the small volume (children), and the stability of the analyte. Many assays in DBS have been reported in the literature over the previous 5 years. These assays and their analytical techniques are reviewed here. Factors that may influence the accuracy and reproducibility of DBS methods are also discussed. Important issues are the correlation with plasma/serum concentrations and the influence of hematocrit on spot size and recovery. The different substrate materials are considered. DBS sampling can be a valid alternative to conventional venous sampling. However, patient correlation studies are indispensable to prove this. Promising developments are dried plasma spots using membrane and hematocrit correction using the potassium concentration.</description><subject>Biological and medical sciences</subject><subject>Blood Specimen Collection</subject><subject>Dried Blood Spot Testing - methods</subject><subject>Dried Blood Spot Testing - trends</subject><subject>Drug Monitoring - methods</subject><subject>Drug Monitoring - trends</subject><subject>General pharmacology</subject><subject>Hematocrit</subject><subject>Humans</subject><subject>Immunosuppressive Agents - blood</subject><subject>Internal Medicine</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Netherlands</subject><subject>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Plasma - chemistry</subject><subject>Reproducibility of Results</subject><subject>Review</subject><subject>Review Article</subject><subject>Tandem Mass Spectrometry</subject><issn>0312-5963</issn><issn>1179-1926</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kV-LFSEYhyWK9nTqA3QTQgTdTPlvdOwiqD1tBRsFbXQpzvjOWZc5OqkT7LfPwzltW9CFKPr48319EHpMyQtKiHqZBWGSNYSKOpRq1B20olTphmom76IV4ZQ1rZb8BD3I-YoQ0jFC7qMT1jIiBOEr9P3iEpKdYSl-wJu0bPGnGHyJyYct7q_rlgeH304xOvx1juUV_pLiNkHOuES8sQWwDQ6fLWVJgDc-wVB8DPkhujfaKcOj47xG387eXZx-aM4_v_94-ua8GVopS9OqVlPHJFgx0LrWHe9ED0Cdls6NHeG91L2EjmmtgbnO8q4bJTDZguSt42v0-pA7L_0O3AChJDuZOfmdTdcmWm_-Pgn-0mzjTyMY5VypGvD8GJDijwVyMTufB5gmGyAu2VBJNadc1t9ao6f_oFdxSaG2VylBFNdE80rRAzWkmHOC8aYYSsxemzloM1Wb2Wsz-yKe3O7i5sZvTxV4dgRsHuw0JhsGn_9wneZCCVY5duDyvDcI6VaJ_339F2iErug</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Wilhelm, Abraham J.</creator><creator>den Burger, Jeroen C. G.</creator><creator>Swart, Eleonora L.</creator><general>Springer International Publishing</general><general>Adis International</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141101</creationdate><title>Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions</title><author>Wilhelm, Abraham J. ; den Burger, Jeroen C. G. ; Swart, Eleonora L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c566t-57591d26ea4c175998384bee1d96ddf803b69b6e82999e2d8a388f6e265e635d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biological and medical sciences</topic><topic>Blood Specimen Collection</topic><topic>Dried Blood Spot Testing - methods</topic><topic>Dried Blood Spot Testing - trends</topic><topic>Drug Monitoring - methods</topic><topic>Drug Monitoring - trends</topic><topic>General pharmacology</topic><topic>Hematocrit</topic><topic>Humans</topic><topic>Immunosuppressive Agents - blood</topic><topic>Internal Medicine</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Netherlands</topic><topic>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Plasma - chemistry</topic><topic>Reproducibility of Results</topic><topic>Review</topic><topic>Review Article</topic><topic>Tandem Mass Spectrometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilhelm, Abraham J.</creatorcontrib><creatorcontrib>den Burger, Jeroen C. G.</creatorcontrib><creatorcontrib>Swart, Eleonora L.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical pharmacokinetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilhelm, Abraham J.</au><au>den Burger, Jeroen C. G.</au><au>Swart, Eleonora L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions</atitle><jtitle>Clinical pharmacokinetics</jtitle><stitle>Clin Pharmacokinet</stitle><addtitle>Clin Pharmacokinet</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>53</volume><issue>11</issue><spage>961</spage><epage>973</epage><pages>961-973</pages><issn>0312-5963</issn><eissn>1179-1926</eissn><coden>CPKNDH</coden><abstract>This article discusses dried blood spot (DBS) sampling in therapeutic drug monitoring (TDM). The most important advantages of DBS sampling in TDM are the minimally invasive procedure of a finger prick (home sampling), the small volume (children), and the stability of the analyte. Many assays in DBS have been reported in the literature over the previous 5 years. These assays and their analytical techniques are reviewed here. Factors that may influence the accuracy and reproducibility of DBS methods are also discussed. Important issues are the correlation with plasma/serum concentrations and the influence of hematocrit on spot size and recovery. The different substrate materials are considered. DBS sampling can be a valid alternative to conventional venous sampling. However, patient correlation studies are indispensable to prove this. Promising developments are dried plasma spots using membrane and hematocrit correction using the potassium concentration.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>25204403</pmid><doi>10.1007/s40262-014-0177-7</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0312-5963 |
| ispartof | Clinical pharmacokinetics, 2014-11, Vol.53 (11), p.961-973 |
| issn | 0312-5963 1179-1926 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4213377 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Biological and medical sciences Blood Specimen Collection Dried Blood Spot Testing - methods Dried Blood Spot Testing - trends Drug Monitoring - methods Drug Monitoring - trends General pharmacology Hematocrit Humans Immunosuppressive Agents - blood Internal Medicine Medical sciences Medicine Medicine & Public Health Netherlands Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacotherapy Plasma - chemistry Reproducibility of Results Review Review Article Tandem Mass Spectrometry |
| title | Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A01%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Drug%20Monitoring%20by%20Dried%20Blood%20Spot:%20Progress%20to%20Date%20and%20Future%20Directions&rft.jtitle=Clinical%20pharmacokinetics&rft.au=Wilhelm,%20Abraham%20J.&rft.date=2014-11-01&rft.volume=53&rft.issue=11&rft.spage=961&rft.epage=973&rft.pages=961-973&rft.issn=0312-5963&rft.eissn=1179-1926&rft.coden=CPKNDH&rft_id=info:doi/10.1007/s40262-014-0177-7&rft_dat=%3Cproquest_pubme%3E1619313640%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1640739093&rft_id=info:pmid/25204403&rfr_iscdi=true |